156 related articles for article (PubMed ID: 20586680)
1. Adoptive antifungal T cell immunotherapy--into the clinic?
Lehrnbecher T; Schmidt S; Koehl U; Schuster FR; Uharek L; Klingebiel T; Tramsen L
Med Mycol; 2011 Apr; 49 Suppl 1():S164-9. PubMed ID: 20586680
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy against invasive fungal diseases in stem cell transplant recipients.
Lehrnbecher T; Tramsen L; Koehl U; Schmidt S; Bochennek K; Klingebiel T
Immunol Invest; 2011; 40(7-8):839-52. PubMed ID: 21627412
[TBL] [Abstract][Full Text] [Related]
3. Adoptive immunotherapy with virus-specific T cells.
Fuji S; Kapp M; Grigoleit GU; Einsele H
Best Pract Res Clin Haematol; 2011 Sep; 24(3):413-9. PubMed ID: 21925094
[TBL] [Abstract][Full Text] [Related]
4. Adoptive cell therapies for posttransplant infections.
Sutrave G; Gottlieb DJ
Curr Opin Oncol; 2019 Nov; 31(6):574-590. PubMed ID: 31593976
[TBL] [Abstract][Full Text] [Related]
5. Facilitating T-cell immune reconstitution after haploidentical transplantation in adults.
Waller EK; Giver CR; Rosenthal H; Somani J; Langston AA; Lonial S; Roback JD; Li JM; Hossain MS; Redei I
Blood Cells Mol Dis; 2004; 33(3):233-7. PubMed ID: 15528137
[TBL] [Abstract][Full Text] [Related]
6. Clinical-scale generation of multi-specific anti-fungal T cells targeting Candida, Aspergillus and mucormycetes.
Tramsen L; Schmidt S; Boenig H; Latgé JP; Lass-Flörl C; Roeger F; Seifried E; Klingebiel T; Lehrnbecher T
Cytotherapy; 2013 Mar; 15(3):344-51. PubMed ID: 23579059
[TBL] [Abstract][Full Text] [Related]
7. Adoptive immunotherapy with genetically modified lymphocytes in allogeneic stem cell transplantation.
Cieri N; Mastaglio S; Oliveira G; Casucci M; Bondanza A; Bonini C
Immunol Rev; 2014 Jan; 257(1):165-80. PubMed ID: 24329796
[TBL] [Abstract][Full Text] [Related]
8. Cytomegalovirus-specific T cell immunotherapy promotes restoration of durable functional antiviral immunity following allogeneic stem cell transplantation.
Peggs KS; Verfuerth S; Pizzey A; Chow SL; Thomson K; Mackinnon S
Clin Infect Dis; 2009 Dec; 49(12):1851-60. PubMed ID: 19911966
[TBL] [Abstract][Full Text] [Related]
9. Primary antifungal prophylaxis in adult hematopoietic stem cell transplant recipients: current therapeutic concepts.
McCoy D; Depestel DD; Carver PL
Pharmacotherapy; 2009 Nov; 29(11):1306-25. PubMed ID: 19857148
[TBL] [Abstract][Full Text] [Related]
10. Clinical grade generation of hexon-specific T cells for adoptive T-cell transfer as a treatment of adenovirus infection after allogeneic stem cell transplantation.
Feuchtinger T; Richard C; Joachim S; Scheible MH; Schumm M; Hamprecht K; Martin D; Jahn G; Handgretinger R; Lang P
J Immunother; 2008; 31(2):199-206. PubMed ID: 18481389
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic purging of alloreactive T cells for adoptive immunotherapy after haploidentical stem cell transplantation.
Perruccio K; Topini F; Tosti A; Carotti A; Aloisi T; Aversa F; Martelli MF; Velardi A
Blood Cells Mol Dis; 2008; 40(1):76-83. PubMed ID: 17977031
[TBL] [Abstract][Full Text] [Related]
13. Strategies to accelerate immune recovery after allogeneic hematopoietic stem cell transplantation.
Lucarelli B; Merli P; Bertaina V; Locatelli F
Expert Rev Clin Immunol; 2016; 12(3):343-58. PubMed ID: 26588325
[TBL] [Abstract][Full Text] [Related]
14. Adenoviral infections in hematopoietic stem cell transplantation.
Leen AM; Bollard CM; Myers GD; Rooney CM
Biol Blood Marrow Transplant; 2006 Mar; 12(3):243-51. PubMed ID: 16503493
[TBL] [Abstract][Full Text] [Related]
15. Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation.
Feuchtinger T; Matthes-Martin S; Richard C; Lion T; Fuhrer M; Hamprecht K; Handgretinger R; Peters C; Schuster FR; Beck R; Schumm M; Lotfi R; Jahn G; Lang P
Br J Haematol; 2006 Jul; 134(1):64-76. PubMed ID: 16803570
[TBL] [Abstract][Full Text] [Related]
16. Innovative approaches of adoptive immune cell therapy in paediatric recipients of haematopoietic stem cell transplantation.
Locatelli F; Comoli P; Montagna D; Rossi F; Daudt L; Maccario R
Best Pract Res Clin Haematol; 2004 Sep; 17(3):479-92. PubMed ID: 15498718
[TBL] [Abstract][Full Text] [Related]
17. [The clinical characteristic and risk factors for the incidence of invasive fungal infection in patients following allogeneic hematopoietic stem cell transplantation].
Zhang Y; Liu C; Liu QF; Sun J; Fan ZP; Xu D; Jiang QL
Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(40):2814-7. PubMed ID: 20137659
[TBL] [Abstract][Full Text] [Related]
18. T-cell therapy after hematopoietic stem cell transplantation.
Kennedy-Nasser AA; Brenner MK
Curr Opin Hematol; 2007 Nov; 14(6):616-24. PubMed ID: 17898565
[TBL] [Abstract][Full Text] [Related]
19. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
20. Primary allogeneic T-cell responses against mantle cell lymphoma antigen-presenting cells for adoptive immunotherapy after stem cell transplantation.
Hoogendoorn M; Olde Wolbers J; Smit WM; Schaafsma MR; Jedema I; Barge RM; Willemze R; Falkenburg JH
Clin Cancer Res; 2005 Jul; 11(14):5310-8. PubMed ID: 16033850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
